The Food and Drug Administration has released its "Strategic Plan for Regulatory Science," defined as "the science of developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products."

One of eight priority areas is substantially enhancing FDA's information technology infrastructure. Better I.T. will open opportunities to better monitor adverse trends and disease outbreaks; combine data from multiple clinical trials, preclinical work and postmarket studies; evaluate and compare the safety and effectiveness of products; host genomics data; and conduct large scale data- and text-mining for research purposes, according to the agency.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access